Paracrine effect of CXCR4-overexpressing mesenchymal stem cells on ischemic heart injury

Cell Biochemistry and Function

Volumn 35, Issue 2, 2017, Pages 113-123

  Wu, Shi Zheng ^a   Li, Ying Lan ^a,b,d   Huang, Wei ^d   Cai, Wen Feng ^d   Liang, Jialiang ^d   Paul, Christian ^d   Jiang, Lin ^d   Wu, Zhi Chao ^c,d   Xu, Meifeng ^d   Zhu, Ping ^c   Wang, Yigang ^d  

^a Department of Dermatology   (China)

^b QINGHAI UNIVERSITY   (China)

^c GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

CXCR4 receptor; myocardial infarction; proliferation; stem cells

Indexed keywords

CD31 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CYCLIN A2; ENHANCED GREEN FLUORESCENT PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA2; VASCULOTROPIN; CCNA2 PROTEIN, RAT; CONDITIONED MEDIUM; CXCR4 PROTEIN, RAT; GREEN FLUORESCENT PROTEIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A;

ADULT; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC MUSCLE CELL; CARDIOVASCULAR PARAMETERS; CELL DIFFERENTIATION; CELL PROLIFERATION; CONDITIONED MEDIUM; CONTROLLED STUDY; CYTOKINE RESPONSE; CYTOKINESIS; DNA SYNTHESIS; FEMALE; GENE OVEREXPRESSION; HEART INFARCTION; HEART MUSCLE FIBROSIS; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE REMODELING; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; LEFT VENTRICULAR FREE WALL THICKNESS; MALE; MESENCHYMAL STEM CELL; MITOSIS; NEWBORN; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL HYPOXIA; CYTOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; MYOCARDIAL INFARCTION; PATHOLOGY; PHARMACOLOGY; PRIMARY CELL CULTURE; REPORTER GENE; SPRAGUE DAWLEY RAT;

ANIMALS; ANIMALS, NEWBORN; CELL HYPOXIA; CULTURE MEDIA, CONDITIONED; CYCLIN A2; GENE EXPRESSION REGULATION; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC; PARACRINE COMMUNICATION; PRIMARY CELL CULTURE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CXCR4; RNA, SMALL INTERFERING; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA2; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VENTRICULAR REMODELING;

EID: 85013628050     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.3254     Document Type: Article

References (26)

1. Ueno H, Perryman MB, Roberts R, Schneider MD. Differentiation of cardiac myocytes after mitogen withdrawal exhibits three sequential states of the ventricular growth response. J Cell Biol. 1988;107:1911-1918.
2. Tamamori-Adachi M, Goto I, Yamada K, Kitajima S. Differential regulation of cyclin D1 and D2 in protecting against cardiomyocyte proliferation. Cell Cycle. 2008;7:3768-3774. doi: 10.4161/cc.7.23.7239
3. Kühn B, del Monte F, Hajjar RJ, et al. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat Med. 2007;13:962-969. doi: 10.1038/nm1619
4. Engel FB, Hsieh PC, Lee RT, Keating MT. FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction. Proc Natl Acad Sci U S A. 2006;103:15546-11551. doi: 10.1073/pnas.0607382103
5. Tamamori-Adachi M, Ito H, Sumrejkanchanakij P, et al. Critical role of cyclin D1 nuclear import in cardiomyocyte proliferation. Circ Res. 2003;92:e12-e19.
6. Cheng RK, Asai T, Tang H, et al. Cyclin A2 induces cardiac regeneration after myocardial infarction and prevents heart failure. Circ Res. 2007;100:1741-1748. doi: 10.1161/CIRCRESAHA.107.153544
7. Dai P, Nakagami T, Tanaka H, Hitomi T, Takamatsu T. Cx43 mediates TGF-beta signaling through competitive Smads binding to microtubules. Mol Biol Cell. 2007;18:2264-2273. doi: 10.1091/mbc.E06-12-1064
8. Kucia M, Reca R, Miekus K, et al. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells. 2005;23:879-894. doi: 10.1634/stemcells.2004-0342
9. + tissue-committed stem cells. Biol Cell. 2005;97:133-146. doi: 10.1042/BC20040069
10. Ma FX, Han ZC. Statins, nitric oxide and neovascularization. Cardiovasc Drug Rev. 2005;23:281-292.
11. Huang W, Zhang D, Millard RW, et al. Gene manipulated peritoneal cell patch repairs infarcted myocardium. J Mol Cell Cardiol. 2010;48:702-712. doi: 10.1016/j.yjmcc.2009.10.032
12. Xu M, Wang Y, Hirai K, Ayub A, Ashraf M. Calcium preconditioning inhibits mitochondrial permeability transition and apoptosis. Am J Physiol Heart Circ Physiol. 2001;280:H899-H908.
13. Pasumarthi KB, Field LJ. Cardiomyocyte cell cycle regulation. Circ Res. 2002;90:1044-1054.
14. Dai Y, Ashraf M, Zuo S, et al. Mobilized bone marrow progenitor cells serve as donors of cytoprotective genes for cardiac repair. J Mol Cell Cardiol. 2008;44:607-617. doi: 10.1016/j.yjmcc.2007.11.011
15. Pasha Z, Wang Y, Sheikh R, Zhang D, Zhao T, Ashraf M. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc Res. 2008;77:134-142. doi: 10.1093/cvr/cvm025
16. Wang Y, Ahmad N, Wang B, Ashraf M. Chronic preconditioning: a novel approach for cardiac protection. Am J Physiol Heart Circ Physiol. 2007;292:H2300-H2305. doi: 10.1152/ajpheart.01163.2006
17. Wang Y, Ahmad N, Wani MA, Ashraf M. Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis. J Mol Cell Cardiol. 2004;37:1041-1052. doi: 10.1016/j.yjmcc.2004.09.004
18. Busk PK, Hinrichsen R, Bartkova J, et al. Cyclin D2 induces proliferation of cardiac myocytes and represses hypertrophy. Exp Cell Res. 2005;304:149-161. doi: 10.1016/j.yexcr.2004.10.022
19. Singla DK, Sun B. Transforming growth factor-beta 2 enhances differentiation of cardiac myocytes from embryonic stem cells. Biochem Biophys Res Commun. 2005;332:135-141. doi: 10.1016/j.bbrc.2005.04.098
20. Bruder SP, Jaiswal N, Haynesworth SE. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem. 1997;64:278-294.
21. Leri A, Kajstura J, Anversa P. Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev. 2005;85:1373-1416. doi: 10.1152/physrev.00013.2005
22. Mangi AA, Noiseux N, Kong D, et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med. 2003;9:1195-1201. doi: 10.1038/nm912
23. Cai B, Tan X, Zhang Y, et al. Mesenchymal stem cells and cardiomyocytes interplay to prevent myocardial hypertrophy. Stem Cells Transl Med. 2015;4:1425-1435. doi: 10.5966/sctm.2015-0032
24. Wang Y, Haider HKH, Ahmad N, Zhang D, Ashraf M. Evidence for ischemia induced host derived bone marrow cell mobilization into cardiac allografts. J Mol Cell Cardiol. 2006;41:478-487. doi: 10.1016/j.yjmcc.2006.06.074
25. Fukuda K, Yuasa S. Stem cells as a source of regenerative cardiomyocytes. Circ Res. 2006;98:1002-1013. doi: 10.1161/01.RES.0000218272.18669.6e
26. Wang Y, Haider HK, Ahmad N, et al. Combining pharmacological mobilization with intramyocardial delivery of bone marrow cells over-expressing VEGF is more effective for cardiac repair. J Mol Cell Cardiol. 2006;40:736-745. doi: 10.1016/j.yjmcc.2006.02.004